Medically reviewed by Drugs.com. Last updated on March 22, 2021.
Generic name: diatrizoate meglumine
Dosage form: injection
Preparation of the patient: Appropriate preparation is desirable for optimal results. A laxative the night before the examination and a low residue diet the day before the procedure are recommended.
Dosage: The usual dose for patients aged 16 years or more is 15 mL for unilateral and appropriately increased volumes for bilateral pyelograms. Approximately 5 to 6 mL will generally be required for each exposure. The dosage for children should be proportionately smaller than the adult dose.
As supplied, the preparation provides maximum opacification. If a lesser contrast is desired, it may be diluted with sterile distilled water.
Administration: Reno-30 may be introduced by a gravity flow system or by syringe. When the syringe method is used, the injections should be made slowly and care should be exercised to use as little manual pressure as possible. Regardless of the system used, injection of the contrast medium should be terminated as soon as the patient complains of a sense of fullness or pain in the renal region.
More about Reno-30 (diatrizoate)
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- Drug class: ionic iodinated contrast media
- FDA Alerts (1)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.